Novartis

Novartis AG, a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States (global research), is one of the largest pharmaceutical companies in the world. The global behemoth has 108,000 associates and businesses in approximately 155 countries and reached 766 million patients with its medicines in 2021.

Novartis AG is a holding company that engages in developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and comprises two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines and intermediary products, including active pharmaceutical ingredients.

Their purpose is to reimagine medicine to improve and extend people’s lives. They use innovative science and technology to address some of society’s most challenging healthcare issues. Their goal is to discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. They also aim to reward those who invest their money, time and ideas in the company.

Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks via its 2 divisions.

Innovative Medicines

Innovative Medicines, made up of two separate commercial organizations, Innovative Medicines International and Innovative Medicines US, commercializes innovative patented medicines to enhance health outcomes.

Sandoz

Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines

People Perspective

They want to build a diverse and inclusive workplace where everyone can be their best and true selves, so that together they can discover more, reach underserved communities and reimagine medicine.

The company constantly reimagines how their people work and creates a culture that brings out the best in people to fulfil their purpose of reimagining medicine to improve and extend people’s lives. The company strongly believes it can drive innovation, performance and reputation, and enhance people’s work experience by transforming culture into more inspired, curious and unbossed. The company seeks to educate its people on inclusivity and provide all associates with equal opportunities to contribute to the company and advance their careers.

Novartis uses science-based innovation to address some of society’s most challenging healthcare issues. As a global company, the company understands its; responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.

They listen to different communities with a learning mindset to do what they can to contribute to building a world that is safer and more inclusive.

LEADERSHIP

Vasant (Vas) Narasimhan
M.D. Chief Executive Officer

Vasant (Vas) Narasimhan, M.D. Chief Executive Officer took the lead in 2018.

Since becoming CEO of Novartis in 2018, Vas has led a strategic and cultural transformation to build a focused medicines company powered by technology leadership in R&D, data science, world-class commercialization and global access to medicine.

Vas has focused his education and career on improving human health and on his personal purpose of inspiring a healthier world. During and after his medical studies, he worked on public health issues such as HIV/AIDS, malaria and tuberculosis in India, Africa and South America. “I never lose my sense of wonder at how human ingenuity is leading to longer, healthier lives. At Novartis, we are reimagining medicine by using innovative science and technology to address some of society’s most challenging and long-standing healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible,” says the CEO.

Vas joined Novartis in 2005 and has held a range of leadership roles, including Global Head of Development for Novartis Vaccines, and Global Head of Drug Development and Chief Medical Officer. In recognition of his sustained efforts to improve human health, he is an elected member of the National Academy of Medicine in the US.

As CEO, Vas is transforming Novartis to unleash the creativity of employees and make culture a driver of innovation, reputation and performance. Vas has also sparked a digital revolution at Novartis; the company is using data science and digital technology to find new ways to discover and develop medicines and increase efficiency.

Originally from Pittsburgh, Pennsylvania, Vas lives in Basel, Switzerland, with his wife and two sons. A lifelong vegetarian, he is passionate about environmental and wildlife conservation and is an avid reader on topics including history, leadership and philosophy.

Future Outlook

“In order to be at the leading edge of the science, if you want to win in biopharmaceuticals, you have to focus your capital and your energy and your management’s attention on that high-tech space,” said Vas in an interview in response to a question about the future outlook of the business and growth plans.